Einstein Andrew J, Berman Daniel S, Min James K, Hendel Robert C, Gerber Thomas C, Carr J Jeffrey, Cerqueira Manuel D, Cullom S James, DeKemp Robert, Dickert Neal W, Dorbala Sharmila, Fazel Reza, Garcia Ernest V, Gibbons Raymond J, Halliburton Sandra S, Hausleiter Jörg, Heller Gary V, Jerome Scott, Lesser John R, Raff Gilbert L, Tilkemeier Peter, Williams Kim A, Shaw Leslee J
Columbia University Medical Center and New York-Presbyterian Hospital, New York, New York.
Cedars-Sinai Medical Center, Los Angeles, California.
J Am Coll Cardiol. 2014 Apr 22;63(15):1480-9. doi: 10.1016/j.jacc.2013.10.092. Epub 2014 Feb 13.
The current paper details the recommendations arising from an NIH-NHLBI/NCI-sponsored symposium held in November 2012, aiming to identify key components of a radiation accountability framework fostering patient-centered imaging and shared decision-making in cardiac imaging. Symposium participants, working in 3 tracks, identified key components of a framework to target critical radiation safety issues for the patient, the laboratory, and the larger population of patients with known or suspected cardiovascular disease. The use of ionizing radiation during an imaging procedure should be disclosed to all patients by the ordering provider at the time of ordering, and reinforced by the performing provider team. An imaging protocol with effective dose ≤3 mSv is considered very low risk, not warranting extensive discussion or written informed consent. However, a protocol effective dose >20 mSv was proposed as a level requiring particular attention in terms of shared decision-making and either formal discussion or written informed consent. Laboratory reporting of radiation dosimetry is a critical component of creating a quality laboratory fostering a patient-centered environment with transparent procedural methodology. Efforts should be directed to avoiding testing involving radiation, in patients with inappropriate indications. Standardized reporting and diagnostic reference levels for computed tomography and nuclear cardiology are important for the goal of public reporting of laboratory radiation dose levels in conjunction with diagnostic performance. The development of cardiac imaging technologies revolutionized cardiology practice by allowing routine, noninvasive assessment of myocardial perfusion and anatomy. It is now incumbent upon the imaging community to create an accountability framework to safely drive appropriate imaging utilization.
本文详述了2012年11月由美国国立卫生研究院(NIH)下属的国立心肺血液研究所(NHLBI)和国立癌症研究所(NCI)主办的研讨会所产生的建议,旨在确定辐射问责框架的关键组成部分,以促进心脏成像中以患者为中心的成像及共同决策。研讨会参与者分为三个小组开展工作,确定了一个框架的关键组成部分,以针对患者、实验室以及大量已知或疑似患有心血管疾病的患者群体所面临的关键辐射安全问题。在开具检查单时,开具检查单的医生应向所有患者披露成像检查过程中电离辐射的使用情况,并由执行检查的医生团队进行强化说明。有效剂量≤3毫希沃特(mSv)的成像方案被认为风险极低,无需进行广泛讨论或签署书面知情同意书。然而,有人提议将有效剂量>20 mSv的方案作为一个在共同决策方面需要特别关注的级别,需要进行正式讨论或签署书面知情同意书。实验室对辐射剂量测定的报告是创建一个以患者为中心、程序方法透明的高质量实验室的关键组成部分。应努力避免对适应症不恰当的患者进行涉及辐射的检查。计算机断层扫描和核心脏病学的标准化报告及诊断参考水平对于结合诊断性能公开报告实验室辐射剂量水平这一目标而言非常重要。心脏成像技术的发展通过实现对心肌灌注和解剖结构的常规无创评估,彻底改变了心脏病学实践。现在,成像领域有责任创建一个问责框架,以安全地推动合理的成像检查应用。